AU2001291640A1 - Stabilised compositions having antibacterial activity - Google Patents

Stabilised compositions having antibacterial activity

Info

Publication number
AU2001291640A1
AU2001291640A1 AU2001291640A AU9164001A AU2001291640A1 AU 2001291640 A1 AU2001291640 A1 AU 2001291640A1 AU 2001291640 A AU2001291640 A AU 2001291640A AU 9164001 A AU9164001 A AU 9164001A AU 2001291640 A1 AU2001291640 A1 AU 2001291640A1
Authority
AU
Australia
Prior art keywords
silver
composition
antibacterial
derivatives
substituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291640A
Other languages
English (en)
Inventor
Brian Nielsen
Jakob Vange
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coloplast AS
Original Assignee
Coloplast AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coloplast AS filed Critical Coloplast AS
Publication of AU2001291640A1 publication Critical patent/AU2001291640A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
AU2001291640A 2000-09-29 2001-09-26 Stabilised compositions having antibacterial activity Abandoned AU2001291640A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200001451 2000-09-29
DKPA200001451 2000-09-29
PCT/DK2001/000616 WO2002026039A1 (en) 2000-09-29 2001-09-26 Stabilised compositions having antibacterial activity

Publications (1)

Publication Number Publication Date
AU2001291640A1 true AU2001291640A1 (en) 2002-04-08

Family

ID=8159754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291640A Abandoned AU2001291640A1 (en) 2000-09-29 2001-09-26 Stabilised compositions having antibacterial activity

Country Status (9)

Country Link
US (1) US7863264B2 (zh)
EP (1) EP1322168B1 (zh)
JP (1) JP2004509907A (zh)
CN (1) CN1466419A (zh)
AT (1) ATE282957T1 (zh)
AU (1) AU2001291640A1 (zh)
DE (1) DE60107455T2 (zh)
ES (1) ES2231550T3 (zh)
WO (1) WO2002026039A1 (zh)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605751B1 (en) 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
DE60028415T2 (de) 1999-12-30 2007-06-06 Acrymed, Portland Methode und zusammensetzungen für verbesserte abgabevorrichtungen
CN1678277B (zh) 2002-07-29 2010-05-05 艾克里麦德公司 治疗皮肤病的方法和组合物
JP4436050B2 (ja) * 2003-01-23 2010-03-24 株式会社シナネンゼオミック 抗菌性組成物
GB2408206B (en) * 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
KR200336396Y1 (ko) * 2003-08-07 2003-12-18 최영철 샤워기헤드
US7390774B2 (en) * 2004-04-08 2008-06-24 Rohm And Haas Company Antibacterial composition and methods of making and using the same
US7335613B2 (en) * 2004-04-08 2008-02-26 Rohm And Haas Company Fiber substrate with antibacterial finish and methods of making and using the same
US20080063693A1 (en) * 2004-04-29 2008-03-13 Bacterin Inc. Antimicrobial coating for inhibition of bacterial adhesion and biofilm formation
WO2006014917A2 (en) * 2004-07-26 2006-02-09 Kci Licensing, Inc. Method for coating substrate with antimicrobial agent and product formed thereby
NZ552928A (en) 2004-07-30 2011-05-27 Acrymed Inc Antimicrobial silver compositions
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
CN102783499A (zh) 2004-07-30 2012-11-21 金伯利-克拉克环球有限公司 抗微生物的装置和组合物
NZ553024A (en) * 2004-08-03 2009-11-27 Royal College Of Surgeons Ie Phenytoin formulations, and uses thereof in wound healing
US20080156739A1 (en) * 2006-12-29 2008-07-03 King Joseph A Ion enhancement
US20100143430A1 (en) * 2008-12-08 2010-06-10 King Joseph A Antimicrobial agents
US20140014594A1 (en) * 2008-09-11 2014-01-16 Joseph A. King Ion enhancement
US9289378B2 (en) 2004-09-20 2016-03-22 Avent, Inc. Antimicrobial amorphous compositions
EP1741811B1 (en) * 2005-07-07 2007-08-22 Rohm and Haas Company Fiber containing an antimicrobial composition
AU2006222708A1 (en) * 2005-10-07 2007-04-26 Rohm And Haas Company Method for disinfecting or sanitizing a surface
EP1991365B8 (en) 2006-02-08 2015-03-25 Avent, Inc. Methods for forming silver-nanoparticle treated surfaces
WO2007127236A2 (en) 2006-04-28 2007-11-08 Acrymed, Inc. Antimicrobial site dressings
US7520923B2 (en) * 2007-03-22 2009-04-21 Mvp Textiles & Apparel, Inc. Antimicrobial filtration article
US20130302440A1 (en) * 2007-12-11 2013-11-14 Joseph King Antimicrobial surfaces
US9398769B2 (en) * 2008-05-01 2016-07-26 King Technology, Inc Bromate suppression
WO2009134315A2 (en) * 2008-05-01 2009-11-05 King Technology, Inc. Bromate suppression
US8846108B2 (en) * 2008-12-08 2014-09-30 King Technology, Inc. Antimicrobial body affecting products
EP2493820A4 (en) * 2009-10-27 2013-09-25 King Technology Inc WATER TREATMENT
EP2338535B1 (en) * 2009-12-18 2012-08-01 Dentsply IH AB Medical device for short time use with quickly releasable antibacterial agent
US9283735B2 (en) 2010-04-14 2016-03-15 Avery Dennison Corporation Low noise flexible barrier films
CN102120747B (zh) * 2011-01-10 2012-11-28 常州大学 水溶性光稳定银(i)配合物、制备方法及其应用
US8901188B2 (en) 2011-06-16 2014-12-02 Kimberly-Clark Worldwide, Inc. Antimicrobial polyurethane foam and process to make the same
WO2013036312A1 (en) 2011-08-19 2013-03-14 Avery Dennison Corporation Blends of ethylene copolymers and propylene based plastomers in multilayer films for low noise and rf welding
ES2460020T3 (es) * 2011-09-08 2014-05-13 Styron Europe Gmbh Composición anti-amarilleamiento
EP2915665A1 (en) 2011-12-22 2015-09-09 Avery Dennison Corporation Flexible Barrier Films Containing Cyclic Olefins
CN104016923B (zh) * 2014-01-08 2016-08-31 南开大学 苯妥英衍生物及其制备方法和用途
TWI549705B (zh) 2014-12-26 2016-09-21 財團法人工業技術研究院 抗菌複合材料及其製造方法
JP6675200B2 (ja) * 2016-01-04 2020-04-01 平岡織染株式会社 テント構造物用膜材
JP6678032B2 (ja) * 2016-01-04 2020-04-08 平岡織染株式会社 テント構造物用膜材
CA3030759C (en) 2016-07-14 2023-07-25 Hollister Incorporated Hygienic medical devices having hydrophilic coatings and methods of forming the same
CN109248334A (zh) * 2018-08-31 2019-01-22 湖南博隽生物医药有限公司 一种外科手术缝合线用抗菌剂及其制备方法
CN110237291B (zh) * 2019-05-31 2021-05-18 广州市龙能城市运营管理股份有限公司 一种活性炭基除臭杀菌剂及其制备方法
CN110498575A (zh) * 2019-09-12 2019-11-26 广州领沨生物科技有限公司 一种用于家禽养殖场的净水装置
CN111100032B (zh) * 2019-12-23 2023-08-11 陕西理工大学 一种含有乙氧基水杨醛缩1,4-丁二胺的稀土Schiff碱配合物的制备方法及其应用
US20230064034A1 (en) * 2021-08-13 2023-03-02 Onyx Lotus, Llc Light stable liquid disinfectant compositions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2336131A (en) * 1940-11-25 1943-12-07 Charles F Schaffer Process of preparing silver allantoinate
CA949562A (en) 1969-03-17 1974-06-18 Charles L. Fox (Jr.) Silver pyrimidines and silver purines and derivatives thereof
US3930000A (en) * 1971-06-16 1975-12-30 Univ Washington Silver-zinc allantoinate compositions and method of killing bacteria and fungi therewith
DE2260536C3 (de) 1972-12-11 1975-07-10 Fa. H. Trommsdorff, 5100 Aachen MolekiileinschluBverbindungen aus einem Silberalkanolammin-Komplex und beta-Cycloheptaamylose, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4172140A (en) * 1977-08-19 1979-10-23 Glyco Chemicals, Inc. Antimicrobial hydantoin derivative compositions and method of use
CA1242204A (en) 1984-01-16 1988-09-20 Sigmund E. Lasker Organometallic diphenyl hydantoins and uses thereof
US5298624A (en) * 1984-01-16 1994-03-29 Lasker Sigmund E Organometallic diphenyl hydantoin
DK154806C (da) 1986-12-19 1989-06-26 Coloplast As Saarplejemiddel indeholdende et aktivt stof til fremme af saarbehandlingen og fremgangsmaade til fremstilling deraf
ATE181822T1 (de) 1991-04-10 1999-07-15 Christopher C Capelli Antimikrobielle zusammensetzungen für medizinische anwendungen
DK122791D0 (da) 1991-06-24 1991-06-24 Coloplast As Saarbandage
US5429819A (en) 1992-10-14 1995-07-04 Matsushita Electric Industrial Co., Ltd. Antiviral composition
US5869494A (en) * 1995-02-13 1999-02-09 Gulliya; Kirpal S. Uses for barbituric acid analogs
US6210556B1 (en) 1998-02-12 2001-04-03 Learonal, Inc. Electrolyte and tin-silver electroplating process
DK75998A (da) 1998-05-29 1999-11-30 Coloplast As Sårbandage
JP2000016904A (ja) 1998-07-01 2000-01-18 Tokuriki Kagaku Kenkyusho:Kk 抗菌抗かび剤および抗菌抗かび材料
GB2340398C (en) 1998-08-13 2007-03-16 Bristol Myers Squibb Co Improvements relating to ostomy pouches
DE69917285T2 (de) * 1998-08-14 2005-05-19 Coloplast A/S Stabilisierte zusammensetzungen mit antibakterieller wirksamkeit
US20020172709A1 (en) * 2001-03-30 2002-11-21 Brian Nielsen Medical dressing comprising an antimicrobial silver compound and a method for enhancing wound healing

Also Published As

Publication number Publication date
ATE282957T1 (de) 2004-12-15
JP2004509907A (ja) 2004-04-02
ES2231550T3 (es) 2005-05-16
WO2002026039A1 (en) 2002-04-04
CN1466419A (zh) 2004-01-07
EP1322168A1 (en) 2003-07-02
US20030186955A1 (en) 2003-10-02
DE60107455D1 (de) 2004-12-30
EP1322168B1 (en) 2004-11-24
US7863264B2 (en) 2011-01-04
DE60107455T2 (de) 2005-12-29

Similar Documents

Publication Publication Date Title
EP1322168B1 (en) Stabilised compositions having antibacterial activity
EP1104311B1 (en) Stabilised compositions having antibacterial activity
US10251392B2 (en) Antimicrobial devices and compositions
US8821916B2 (en) Medical dressing comprising an antimicrobial silver compound
EP2398508B1 (en) Superabsorbent materials comprising peroxide
US7147845B2 (en) Antimicrobial silver ion complex resinates
JP5774051B2 (ja) 抗微生物材料
TW201505639A (zh) 抗微生物之組成物及其製造方法
WO2014012171A1 (en) Anti-microbial gel formulations containing a silver (i) periodate
US6923990B2 (en) Stabilized silver-ion amine complex compositions and methods
MXPA02009905A (es) Articulos que comprenden polisacaridos cationicos y medios acidos reguladores de ph.
DE60112421T2 (de) Absorbierende artikel mit einem kationischen polysaccharid und einem silikat
US20040214809A1 (en) Stabilized silver-ion sulfite complex compositions and methods

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application